Post-transplant lymphoproliferative disorder presenting as CD20-negative plasmablastic lymphoma in the lung

Tasneem Kaleem, Jennifer A. Crozier, David M. Menke, Taimur Sher

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Post-transplant lymphoproliferative disorders (PTLD) are a serious complication of transplantation with a high mortality. Most PTLD present within the first year of transplantation and are associated with Epstein-Barr virus (EBV) infection. Plasmablastic lymphoma (PBL) is a rare but aggressive disease originally described in patients with HIV, presenting most commonly in the jaw and oral mucosa. To our knowledge, this is the first case of PBL presenting as PTLD of the lung in a HIV and EBV negative patient. Given the increasing number of transplants performed, we would like to share this uncommon presentation of PTLD as PBL.

Original languageEnglish (US)
Article number6220
Pages (from-to)83-84
Number of pages2
JournalRare Tumors
Volume8
Issue number3
DOIs
StatePublished - Sep 5 2016

Keywords

  • Lung
  • Lymphomas
  • Plasmablastic
  • Post-transplant

ASJC Scopus subject areas

  • Histology
  • Oncology

Fingerprint Dive into the research topics of 'Post-transplant lymphoproliferative disorder presenting as CD20-negative plasmablastic lymphoma in the lung'. Together they form a unique fingerprint.

  • Cite this